Rocket, Lab

Rocket Lab Shares Slide as Key Rocket Program Faces Delay

28.02.2026 - 01:13:31 | boerse-global.de

Rocket Lab posted record revenue and a surging backlog, but its stock fell sharply after a key test failure delayed the Neutron rocket's debut to late 2026.

Rocket Lab Shares Slide as Key Rocket Program Faces Delay - Bild: über boerse-global.de
Rocket Lab Shares Slide as Key Rocket Program Faces Delay - Bild: über boerse-global.de

Despite posting record annual revenue and a substantial increase in its order backlog for fiscal year 2025, Rocket Lab USA's stock experienced a sharp sell-off. Investor enthusiasm for the company's operational performance was decisively overshadowed by a significant setback in the development timeline for its next-generation launch vehicle.

Operational Business Reaches New Heights

The company's established business lines are performing exceptionally. Annual revenue for 2025 climbed 38% to reach $602 million. Rocket Lab highlighted the reliability of its workhorse Electron rocket, noting seven successful launches in the fourth quarter alone.

Future indicators remain robust. The company's backlog of orders surged by an impressive 73% year-over-year to a record $1.85 billion. A major contributor to this growth is a contract with the U.S. Space Development Agency for 18 satellites. Furthermore, guidance for the first quarter of 2026 projects continued momentum, with anticipated revenue between $185 million and $200 million.

Neutron Delay Triggers Market Concern

The primary catalyst for the negative market reaction was an update on the Neutron rocket program. This medium-lift vehicle is central to Rocket Lab's strategy for capturing market share in heavier payload and satellite constellation launches. Management announced a delay of the inaugural launch to the fourth quarter of 2026.

This schedule push stems from a failed test of a first-stage tank, attributed to a manufacturing defect. The company stated that the involved processes have already been revised. The news weighed heavily on investor sentiment, with shares dropping approximately 10% in a single session to trade around $65.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Contracts Continue Amid Strategic Pivot

Even with the developmental hurdle, Rocket Lab continues to secure new business for its core services. Concurrent with its earnings release, the company announced a new agreement with data provider BlackSky for four additional Electron missions. It also unveiled new solar modules designed for in-space power generation.

The current situation presents a clear dichotomy. Operationally, Rocket Lab is expanding rapidly and solidifying its market position. However, its long-term valuation is intrinsically linked to the successful debut of the Neutron platform. Investors now face a prolonged waiting period, until late 2026, for the company to demonstrate its competitive viability in the more demanding medium-lift segment.

Ad

Rocket Lab USA Stock: New Analysis - 28 February

Fresh Rocket Lab USA information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated Rocket Lab USA analysis...

en | US7731221062 | ROCKET | boerse | 68619481 |